Credelio is a drug owned by ELANCO US INC. It is protected by 4 US drug patents filed from 2030 to 2041. All patents are active. Details of Credelio’s patents and their expiration are given below.
Exclusivity Information
Credelio holds 2 exclusivitys out of which 1 has expired. Its last outstanding exclusivity is set to expire in 2028. Details of Credelio's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 24, 2028 |
| NCE | Jan 19, 2023 |
About Credelio
Credelio is a drug
owned by ELANCO US INC.
Credelio uses
Lotilaner as the active
ingredient.
Active Ingredient:
Credelio uses
Lotilaner as the active ingredient.
Check out other Drugs and Companies using
Lotilaner ingredient.